{"text_format":"2","workbook":"xls","n_sheets":1,"sheets":["report2"],"not_rendered":{"charts":0,"images":0,"macros":0,"external_links":1,"defined_names":1,"comments":0,"pivot_tables":0},"unopened":[],"bounds":{"document_bytes":16777216,"sheet_cells":100000,"run_cost":"one","rows_first":2000,"rows_last":500,"rows_between":2000,"halvings":0,"cell_chars":16384,"cell_head_chars":4096},"cells_cut":0,"cells_raw":0,"read":"whole","date_system":"1900","formulas":"cached_only"}

{"sheet":"report2","index":0,"n_rows":24,"n_cols":5,"rows_kept":24,"cut":false,"hidden":false,"merged":[[0,2,0,3],[0,4,0,5],[1,2,1,3],[1,4,1,5],[2,2,2,3],[4,2,4,3],[6,2,6,3],[7,2,7,3],[8,2,8,3],[9,2,9,3],[10,2,10,3],[14,2,14,3],[15,2,15,3],[18,2,18,3]],"flags":["formulas_cached_only"]}
[null,"1.","Record Nr.",null,"UNINA9910780901203321"]
[null,null,"Titolo",null,"Modified-release drug delivery technology / / edited by Michael J. Rathbone [et al.]"]
[null,null,"Pubbl/distr/stampa",null,"New York : , : CRC Press, , 2008"]
[{"$nulls":4},"©2013"]
[null,null,"ISBN",null,"0-429-09286-5"]
[{"$nulls":4},"1-4200-4526-1"]
[null,null,"Edizione",null,"[Second edition.]"]
[null,null,"Descrizione fisica",null,"1 online resource (2 volumes) : illustrations"]
[null,null,"Collana",null,"Drugs and the pharmaceutical sciences"]
[null,null,"Disciplina",null,"615/.19"]
[null,null,"Soggetti",null,"Controlled release technology"]
[{"$nulls":4},"Controlled release preparations"]
[{"$nulls":4},"Drug delivery systems"]
[{"$nulls":4},"Pharmaceutical technology"]
[null,null,"Lingua di pubblicazione",null,"Inglese"]
[null,null,"Formato",null,"Materiale a stampa"]
[null,null,null,"Livello bibliografico","Monografia"]
[null,null,null,"Nota di bibliografia","Includes bibliographical references and indexes."]
[null,null,"Nota di contenuto",null,"\"\"Preface\"\"; \"\"Contents\"\"; \"\"Contributors\"\"; \"\"1 The Modified-Release Drug Delivery Landscape\"\"; \"\"2 The Modified-Release Drug Delivery Landscape\"\"; \"\"3 The Modified-Release Drug Delivery Landscape\"\"; \"\"4 The Modified-Release Drug Delivery Landscape\"\"; \"\"5 Ophthalmic Drug Delivery\"\"; \"\"6 Intraocular Implants for Controlled Drug Delivery\"\"; \"\"7 Bioadhesive Ophthalmic Drug Inserts (BODI) for Veterinary Use\"\"; \"\"8 Ion Exchange Resin Technology for Ophthalmic Applications\"\"; \"\"9 Injections and Implants\"\"; \"\"10 Long-Acting Protein Formulation-PLAD Technology\"\""]
[{"$nulls":4},"\"\"11 Long-Term Controlled Delivery of Therapeutic Agents by the Osmotically Driven DUROS Implant\"\"; \"\"12 The SABERTM Delivery System for Parenteral Administration\"\"; \"\"13 Improving the Delivery of Complex Formulations Using the DepotOne Needle\"\"; \"\"14 ReGel Depot Technology\"\"; \"\"15 The Atrigel Drug Delivery System\"\"; \"\"16 Enhancing Drug Delivery by Chemical Modification\"\"; \"\"17 DepoFoam Multivesicular Liposomes for the Sustained Release of Macromolecules\"\"; \"\"18 ALZAMER DepotTM Bioerodible Polymer Technology\"\""]
[{"$nulls":4},"\"\"19 Pegylated Liposome Delivery of Chemotherapeutic Agents: Rationale and Clinical Benefit\"\"; \"\"20 Dermal and Transdermal Drug Delivery\"\"; \"\"21 ALZA Transdermal Drug Delivery Technologies\"\"; \"\"22 "]
[{"$nulls":4},"Microneedles for Drug Delivery\"\"; \"\"23 Transfersome: Self-Optimizing and Self-Driven Drug-Carrier, for Localized and Transdermal Drug Delivery\"\"; \"\"24 Advances in Wound Healing\"\"; \"\"25 Ultrasound-Mediated Transdermal Drug Delivery\"\"; \"\"26 Lipid Nanoparticles with Solid Matrix for Dermal Delivery: Solid Lipid Nanoparticles and Nanostructured Lipid Carriers\"\""]
[{"$nulls":4},"\"\"27 LidoSite-Vyteris Iontophoretic Technology\"\"; \"\"28 Nail Delivery\"\"; \"\"29 Immediate Topical Drug Delivery Using Natural Nano-Injectors\"\"; \"\"30 DOT Matrix Technology\"\"; \"\"31 The PassPortTM System: A New Transdermal Patch for Water-Soluble Drugs, Proteins, and Carbohydrates\"\"; \"\"32 Nasal Drug Delivery\"\"; \"\"33 Controlled Particle Dispersion: A Twenty-First-Century Nasal Drug Delivery Platform\"\"; \"\"34 DirectHalerTM Nasal: Innovative Device and Delivery Method\"\"; \"\"35 Intravaginal Drug Delivery Technologies\"\"; \"\"36 Vaginal Rings for Controlled-Release Drug Delivery\"\""]
[{"$nulls":4},"\"\"37 Phospholipids as Carriers for Vaginal Drug Delivery\"\"; \"\"38 SITE RELEASE, Vaginal Bioadhesive System\"\"; \"\"39 Clindamycin Vaginal Insert\"\"; \"\"40 Bioresponsive Vaginal Delivery Systems\"\"; \"\"41 Pulmonary Delivery of Drugs by Inhalation\"\"; \"\"42 AERx Pulmonary Drug Delivery Systems\"\"; \"\"43 Formulation Challenges of Powders for the Delivery of Small Molecular Weight Molecules as Aerosols\"\"; \"\"44 Adaptive Aerosol Delivery (AAD) Technology\"\"; \"\"45 Nebulizer Technologies\"\"; \"\"46 Formulation Challenges: Protein Powders for Inhalation\"\"  ; \"\"47 The Respimat, a New Soft MistTM Inhaler for Delivering Drugs to the Lungs\"\""]